Skincare company SkinCeuticals has announced the launch of its P-TIOX Cream, set to debut on 15 June.
The company states that the P-TIOX Cream is a wrinkle-and-texture-correcting moisturiser, designed to target the appearance of deep-set lines, reduce visible pore size and provide immediate hydration. According to SkinCeuticals, the formula contains a patent-pending complex featuring 10% Myrixin and 2% tripeptide technology, which is developed to target visible signs of ageing, enlarged pores and uneven skin texture.
SkinCeuticals further shares that the product includes niacinamide, lipohydroxy acid and tetrapeptide, which aim to improve skin moisture, radiance and overall skin quality.
Oliver Pearce, medical events and communications manager at SkinCeuticals, commented, “We are delighted to announce the launch of our next innovation, P-TIOX Cream. Building on the success of our peptide technology, this new addition to the P-TIOX family is designed to complement professional results and empower patients with total skin confidence.”